IBRN Holdings
iShares Neuroscience and Healthcare ETF
1W: -2.3%
1M: -17.5%
3M: -16.6%
YTD: +2.4%
1Y: +22.3%
3Y: +55.7%
$32.55
-0.31 (-0.95%)
Weekly Expected Move ±3.3%
$30
$31
$33
$34
$35
Overview
Chart
Holdings
Changes
Technicals
Analysis
Peers
Institutions
Dark Pool
Short Interest
Dividends
Weather
ETF-Level Metrics
AUM$5M
Holdings67
Top 10 Wt41.1%
Beta0.87
% Profitable16%
Coverage95%
Portfolio Valuation
P/E15.3
P/B5.7
P/S6.8
EV/EBITDA23.8
P/FCF24.5
PEG13.77
Profitability & Returns
Gross Margin91.7%
Net Margin44.0%
ROE45.8%
ROA30.8%
ROIC53.9%
Div Yield0.12%
Leverage & Liquidity
Debt/Equity0.07
Debt/Assets0.05
Net Debt/EBITDA-1.3x
Interest Cov33.4x
Current Ratio2.71
Quick Ratio2.41
Growth (YoY)
Revenue+8.0%
Net Income-11.7%
EPS-2.7%
FCF-0.2%
EBITDA-8.1%
Rev CAGR 3Y+39.7%
Quality Scores
Piotroski F3.6
Altman Z26.74
IS Quality58.3
IS Overall46.8
IS Value39.0
Median P/E-4.6
Sector Breakdown
2 sectors| Sector | # Holdings | Total Weight % | Avg P/E |
|---|---|---|---|
| Healthcare | 67 | 98.6% | -12.3 |
| Other | 16 | 1.4% | — |
Smart Money Overlap
0 holdings with signalsNo holdings with active convergence signals
Showing 50 of 83 holdings
· Page 1 of 2
| # | Name | Ticker | Weight % ▼ | Mkt Value | Shares | P/E | Mkt Cap | Sector |
|---|---|---|---|---|---|---|---|---|
| 1 | BIOGEN | BIIB | 4.78% | $319,251 | 1,396 | 38.7 | $32.5B | Healthcare |
| 2 | PTC THERAPEUTICS | PTCT | 4.39% | $293,214 | 4,446 | -129.5 | $5.3B | Healthcare |
| 3 | ARGENX SE ADR | ARGX | 4.35% | $290,703 | 299 | 33.2 | $57.2B | Healthcare |
| 4 | EDGEWISE THERAPEUTICS | EWTX | 4.26% | $284,419 | 7,148 | -22.4 | $4.5B | Healthcare |
| 5 | NEUROCRINE BIOSCIENCES | NBIX | 4.16% | $278,212 | 1,981 | 20.3 | $14.4B | Healthcare |
| 6 | SCHOLAR ROCK HOLDING | SRRK | 4.09% | $273,408 | 5,565 | -14.1 | $5.6B | Healthcare |
| 7 | ALKERMES | ALKS | 4.02% | $268,443 | 6,686 | 103.6 | $7.0B | Healthcare |
| 8 | DIANTHUS THERAPEUTICS INC | DNTH | 3.74% | $250,140 | 2,848 | -678.5 | $4.9B | Healthcare |
| 9 | PRAXIS PRECISION MEDICINES | PRAX | 3.74% | $249,944 | 875 | -22.8 | $8.2B | Healthcare |
| 10 | SUPERNUS PHARMACEUTICALS | SUPN | 3.54% | $236,335 | 5,299 | -22.1 | $2.5B | Healthcare |
| 11 | ACADIA PHARMACEUTICALS | ACAD | 3.38% | $225,727 | 10,995 | 8.9 | $3.4B | Healthcare |
| 12 | AXOGEN | AXGN | 3.32% | $221,916 | 5,118 | -55.4 | $2.0B | Healthcare |
| 13 | SK BIOPHARMACEUTICALS LTD | 326030.KS | 3.18% | $212,729 | 3,810 | 15.3 | $5.9T | Healthcare |
| 14 | DYNE THERAPEUTICS | DYN | 3.10% | $207,224 | 12,682 | -4.6 | $2.8B | Healthcare |
| 15 | XENON PHARMACEUTICALS | XENE | 2.83% | $189,402 | 5,158 | -8.0 | $3.7B | Healthcare |
| 16 | SAREPTA THERAPEUTICS | SRPT | 2.76% | $184,672 | 9,823 | -12.2 | $1.8B | Healthcare |
| 17 | H. LUNDBECK CLASS B | HLUN-B.CO | 2.67% | $178,510 | 26,061 | 11.2 | $34.6B | Healthcare |
| 18 | BIOHAVEN | BHVN | 2.48% | $165,822 | 12,496 | -2.8 | $1.9B | Healthcare |
| 19 | NEUREN PHARMACEUTICALS | NEU.AX | 2.23% | $148,824 | 10,697 | 128.4 | $2.6B | Healthcare |
| 20 | BIOARCTIC CLASS B | BIOA-B.ST | 1.93% | $128,823 | 4,158 | 256.5 | $27.0B | Healthcare |
| 21 | TAYSHA GENE THERAPIES | TSHA | 1.92% | $128,213 | 25,694 | -11.0 | $1.5B | Healthcare |
| 22 | INTEGRA LIFESCIENCES HOLDINGS | IART | 1.59% | $106,129 | 6,523 | -137.5 | $986M | Healthcare |
| 23 | LB PHARMACEUTICALS INC | LBRX | 1.46% | $97,302 | 2,568 | -12.5 | $1.1B | Healthcare |
| 24 | IDORSIA N LTD | IDIA.SW | 1.44% | $96,001 | 18,238 | -3.4 | $1.2B | Healthcare |
| 25 | ONCOLYS BIOPHARMA INC | 4588.T | 1.41% | $94,065 | 2,600 | -109.9 | $175.1B | Healthcare |
| 26 | RAPPORT THERAPEUTICS | RAPP | 1.40% | $93,298 | 2,790 | -10.6 | $1.5B | Healthcare |
| 27 | ALTO NEUROSCIENCE INC | ANRO | 1.38% | $92,004 | 3,451 | -10.0 | $870M | Healthcare |
| 28 | RUBICON RESEARCH Private | — | 1.25% | $83,299 | 5,020 | — | — | — |
| 29 | APNIMED INC | APMD | 1.22% | $81,588 | 3,765 | — | $857M | Healthcare |
| 30 | DYNAVOX GROUP | DYVOX.ST | 1.07% | $71,250 | 9,662 | — | $8.2B | Healthcare |
| 31 | ANNEXON | ANNX | 0.95% | $63,787 | 15,907 | -3.6 | $687M | Healthcare |
| 32 | MEDINCELL SA | MEDCL.PA | 0.93% | $62,336 | 2,299 | -24.4 | $797M | Healthcare |
| 33 | CERIBELL | CBLL | 0.91% | $61,079 | 2,492 | -13.5 | $899M | Healthcare |
| 34 | SOLID BIOSCIENCES INC | SLDB | 0.90% | $60,293 | 8,282 | -3.6 | $674M | Healthcare |
| 35 | METIS TECHBIO CLASS H | 7666.HK | 0.74% | $49,656 | 24,500 | — | $21.9B | Healthcare |
| 36 | BRAINSWAY ADR REPRESENTING LTD | BWAY | 0.71% | $47,395 | 3,577 | 53.4 | $490M | Healthcare |
| 37 | CAPRICOR THERAPEUTICS | CAPR | 0.67% | $44,865 | 5,151 | -3.7 | $515M | Healthcare |
| 38 | NEUROGENE | NGNE | 0.65% | $43,432 | 1,525 | -4.7 | $405M | Healthcare |
| 39 | OVID THERAPEUTICS | OVID | 0.65% | $43,409 | 17,646 | -5.0 | $444M | Healthcare |
| 40 | DESIGN THERAPEUTICS | DSGN | 0.61% | $40,924 | 3,311 | -10.5 | $771M | Healthcare |
| 41 | CLEARPOINT NEURO INC | CLPT | 0.61% | $40,602 | 2,652 | -9.2 | $327M | Healthcare |
| 42 | PROTHENA PLC | PRTA | 0.57% | $38,420 | 4,406 | -10.1 | $438M | Healthcare |
| 43 | BRIGHT MINDS BIOSCIENCES | DRUG.CN | 0.57% | $38,177 | 739 | -24.3 | $691M | Healthcare |
| 44 | NEUROPACE | NPCE | 0.56% | $37,483 | 2,649 | -22.2 | $433M | Healthcare |
| 45 | ZYLOX-TONBRIDGE MEDICAL TECH H | 2190.HK | 0.53% | $35,297 | 13,000 | 19.3 | $6.7B | Healthcare |
| 46 | SANBIO LTD | 4592.T | 0.52% | $34,679 | 5,800 | -19.9 | $73.4B | Healthcare |
| 47 | BENITEC BIOPHARMA INC | BNTC | 0.49% | $32,976 | 3,291 | -9.2 | $309M | Healthcare |
| 48 | VANDA PHARMACEUTICALS INC | VNDA | 0.43% | $29,040 | 5,617 | -1.0 | $278M | Healthcare |
| 49 | ABEONA THERAPEUTICS INC | ABEO | 0.39% | $26,365 | 4,984 | -4.4 | $287M | Healthcare |
| 50 | KYVERNA THERAPEUTICS | KYTX | 0.39% | $25,780 | 3,780 | -2.1 | $378M | Healthcare |